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June Supplement 201164S Abstractsregimes after PTA, stenting, and SAP were ASA-only
(47%), ASA-clopidogrel (38%), and ASA-clopidogrel
(41%), respectively. Type of post-procedure antithrom-
botic therapy did not influence major amputation or death
in claudicants or patients with critical limb ischemia (CLI)
undergoing PTA or SAP. Kaplan-Meier analysis showed
better amputation-free survival and total survival with ASA-
clopidogrel treatment compared to ASA-only in patients
with CLI undergoing stenting (log rank P0.008 and
P0.047, respectively).
Conclusions: Patients with CLI undergoing stenting
in the femoropopliteal segment have insufficient adjuvant
antiplatelet treatment and dual antiplatelet therapy with
ASA and clopidogrel seem to improve amputation-free
survival. Type of post-procedure antiplatelet therapy did
not influence amputation or death in patients with CLI
undergoing PTA or SAP.
Author Disclosures: F. Granath: Nothing to disclose; J.
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An Economic Analysis Regarding the Use of Axial
Imaging Studies for the Anatomic Workup of Periph-
eral Arterial Occlusive Disease
Bryan A. Ehlert, John T. Nelson, Christopher A. Durham,
Alex J. Ferikes, Charles S. Powell, WilliamM. Bogey, Frank
M. Parker, Michael C. Stoner. East Carolina University,
Greenville, NC
Objectives: Within the context of healthcare resource
utilization, the optimal use of computed tomographic ar-
teriography (CTA) for peripheral arterial occlusive disease
is ill-defined. The purpose of this study is to use data from
a contemporary practice to examine the hypothetical im-
pact of non-selective CTA as a part of the workup algorithm
for peripheral arterial occlusive disease.
Methods: Outpatient lower extremity endovascular
cases were analyzed over a consecutive 12-month period.
Indication (claudication or critical limb ischemia), case type
(diagnostic or interventional) and charges were recorded.
Medicare charges for CTAwere used to generate hypothet-
ical charges assuming all patients underwent CTA, and that
diagnostic cases would not have undergone catheter-based
procedures. The ratio of diagnostic to interventional cases
was then examined to define the cost-effective point for
non-selective CTA use.
Results: A total of 211 cases were identified, 47% had an
indication of claudication, and 60% were male. In the claudi-
cation cohort, 32% were diagnostic and the mean current
charge (without the use of CTA) was $45,8733,002/pa-
tient. Non-selective CTA results in a mean charge
of $47,5573,545/patient (P0.72 vs. current). In the crit-
ical limb ischemia subset, 29% were diagnostic, and the mean
current charge was $52,5423,690/patient compared to a
hypothetical non-selective CTA charge of $55,7954,144/atient (P0.55 vs. current). The ratio of diagnostic-to-inter-
entional cases for non-selective CTA to be cost-effective is
.44.
Conclusions:The economic basis for non-selective use
f CTA in the anatomic workup of peripheral arterial
cclusive disease is dependent on the ratio of diagnostic to
nterventional cases. In the authors’ current practice, non-
elective CTA would not improve resource utilization,
owever other factors such as patient access, the invasive
ature of catheter-based procedures, ionizing radiation
osimetry, and iodinated contrast dose all impact this prac-
ice decision.
uthor Disclosures: W. M. Bogey: Nothing to disclose;
. A. Durham: Nothing to disclose; B. A. Ehlert: Nothing
o disclose; A. J. Ferikes: Nothing to disclose; J. T. Nelson:
othing to disclose;F. M. Parker: Nothing to disclose;C. S.
owell: Nothing to disclose; M. C. Stoner: Nothing to
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Objectives: Patients with no option critical limb isch-
mia [NOCLI] have been ascribed a 50% one-year ampu-
ation free survival (AFS) [TASC II]. Over recent years
mprovements in the medical treatments available to NO-
LI patients may affect atherosclerotic peripheral and cor-
nary artery disease. In addition advances in wound care
herapies have improved ulcer healing. We sought to deter-
ine if amputation, mortality, and AFS rates of medically
anaged NOCLI patients have changed over the last two
ecades.
Methods: We reviewed 886 control patients from 11
OCLI randomized controlled trials (RCTs)enrolled from
988 to 2010. We estimated summary proportions of
vents at 1 year by conducting a random effects meta-
nalysis of proportions with the Freeman-Tukey arcsine
ransformation method. To examine whether there is a
ignificant change in the published proportions of these
vents over time, we performed a random effects meta-
egression analysis, where we regressed the proportion of
vents in each study against the indicator variable “final year
f recruitment” in each study. This was used as a proxy
ariable for the time period during which each study was
onducted. We examined the coefficient of this indicator
ariable for direction of effect (positive or negative, show-
ng increase or decrease in proportion of events over time,
espectively).Results: See Table.
